Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

737
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
737
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)00:53

Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)

1.9K
Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
1.9K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

83
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
83
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

95
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
95
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

737
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
737

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The changing landscape of medicinal chemistry optimization.

Nature reviews. Drug discovery·2025
Same author

Scaffold Hopping with Generative Reinforcement Learning.

Journal of chemical information and modeling·2025
Same author

DeepCt: Predicting Pharmacokinetic Concentration-Time Curves and Compartmental Models from Chemical Structure Using Deep Learning.

Molecular pharmaceutics·2024
Same author

Balancing Molecular Size, Activity, Permeability, and Other Properties: Drug Candidates in the Context of Their Chemical Structure Optimization.

Journal of chemical information and modeling·2024
Same author

Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors.

Journal of medicinal chemistry·2024
Same author

Extracting medicinal chemistry intuition via preference machine learning.

Nature communications·2023

相关实验视频

Updated: Jul 14, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

使用大规模在中的ADMET模型预测小分子发展能力.

Maximilian Beckers1, Noé Sturm1, Finton Sirockin1

  • 1Novartis Institutes for BioMedical Research, Novartis Pharma AG, Postfach, 4002 Basel, Switzerland.

Journal of medicinal chemistry
|October 10, 2023
PubMed
概括

这项研究引入了一种新的深度学习方法,用于使用ADMET试验数据预测药物潜力. 与现有方法相比,新的bPK评分显著改善了有前途的候选药物的识别.

科学领域:

  • 计算化学是一种计算化学.
  • 药物发现 药物发现
  • 在药理学中的机器学习.

背景情况:

  • 在计算机辅助药物设计中,对药物化合物潜力的早期评估至关重要.
  • 现有的预测方法往往缺乏足够的准确性,导致非药物类型的候选者.
  • 从广的化学空间中识别有前途的化学序列仍然是一个重大挑战.

研究的目的:

  • 开发一种新的深度学习方法来评估药物化合物潜力.
  • 为了利用大约100个ADMET试验的大规模预测.
  • 引入一种新的评分系统,即bPK评分,用于药物候选者的优先排名.

主要方法:

  • 利用深度学习框架来分析来自众多ADMET试验的预测.
  • 开发并应用了一种新的评分指标,即bPK评分.
  • 在数据集上验证了方法,而以前的方法显示有局限性.

主要成果:

  • 开发的bPK得分显示了比现有方法更优异的性能.
  • 取得了强大的差异性表现,特别是在具有挑战性的数据集上.
  • 成功识别出具有更高潜力成为药物候选物的化合物.

更多相关视频

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.0K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

237

相关实验视频

Last Updated: Jul 14, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.0K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

237

结论:

  • 新的深度学习方法和bPK得分在早期药物发现方面取得了重大进展.
  • 这种方法提高了对潜在候选药物的优先级的准确性和效率.
  • bPK评分提供了更可靠的药物相似性和治疗潜力的评估.